Publicaciones en las que colabora con Miguel Paja Fano (12)

2024

  1. Effectiveness of combined first-line medical treatment in acromegaly with prolactin cosecretion

    European Journal of Endocrinology, Vol. 190, Núm. 6, pp. 458-466

2022

  1. Acromegaly disease activity according to ACRODAT®, a cross-sectional study in Spain: ACROVAL study

    Endocrine, Vol. 75, Núm. 2, pp. 525-536

2021

  1. Craniopharyngioma in the Elderly: A Multicenter and Nationwide Study in Spain

    Neuroendocrinology, Vol. 111, Núm. 10, pp. 925-936

  2. Erratum: Late Recovery of Parathyroid Function after Total Thyroidectomy: A Case-Control Study (Horm Metab Res (2021) 53 DOI: 10.1055/a-1608-1373)

    Hormone and Metabolic Research

  3. Late Recovery of Parathyroid Function after Total Thyroidectomy: A Case-Control Study

    Hormone and Metabolic Research, Vol. 53, Núm. 10, pp. 654-661

  4. Rate of non-invasive follicular thyroid neoplasms with papillary-like nuclear features depends on pathologist’s criteria: a multicentre retrospective Southern European study with prolonged follow-up

    Endocrine, Vol. 73, Núm. 1, pp. 131-140

  5. Recovery of parathyroid function in patients with thyroid cancer treated by total thyroidectomy: An analysis of 685 patients with hypoparathyroidism at discharge of surgery

    Endocrinologia, Diabetes y Nutricion, Vol. 68, Núm. 6, pp. 398-407

2020

  1. Permanent postoperative hypoparathyroidism: an analysis of prevalence and predictive factors for adequacy of control in a cohort of 260 patients

    Gland Surgery, Vol. 9, Núm. 5, pp. 1380-1388

2019

  1. Correction to: Prevalence and risk factors for hypoparathyroidism following total thyroidectomy in Spain: a multicentric and nation-wide retrospective analysis (Endocrine, (2019), 66, 2, (405-415), 10.1007/s12020-019-02014-8)

    Endocrine

  2. Prevalence and risk factors for hypoparathyroidism following total thyroidectomy in Spain: a multicentric and nation-wide retrospective analysis

    Endocrine, Vol. 66, Núm. 2, pp. 405-415

2016

  1. Use of lanreotide in combination with cabergoline or pegvisomant in patients with acromegaly in the clinical practice: The ACROCOMB study

    Endocrinología y nutrición: órgano de la Sociedad Española de Endocrinología y Nutrición, Vol. 63, Núm. 8, pp. 397-408

1992

  1. Miopatía hipocaliémica grave como presentación del aldosteronismo primario.

    Medicina Clinica